The Food and Drug Administration's process for approving new drugs : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology
Language:	English
Published:	Washington : U.S. Govt. Print. Off, 1979.
Series:	Serial - House, Committee on Science and Technology ; no. 96-37
Subjects:	United States. > Food and Drug Administration. Pharmaceutical policy > United States.
Physical Description:	iv, 1,299 pages : illustrations ; 24 cm.
Format:	Government Document Microfilm Book

Similar Items

The Food and Drug Administration's process for approving new drugs : report
Published: (1980)

FDA's drug approval process up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

The Quayle Council's plans for changing FDA's drug approval process : a prescription for harm : twenty-sixth report
Published: (1992)

The Quayle Council's plans for changing FDA's drug approval process : a prescription for harm : twenty-sixth report
Published: (1992)

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

FDA's generic drug enforcement and approval process hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

Handbook of food-drug interactions
Published: (2003)

Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities.
Published: (2002)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

The drug development process
Published: (1996)

FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)

FDA drug approval : a lengthy process that delays the availability of important new drugs : summary : report to the Subcommittee on Science, Research, and Technology, House Committee on Science and Technology
Published: (1980)

Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities : report to the chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate
Published: (2002)

Top drugs : their history, pharmacology, syntheses
by: Li, Jie Jack
Published: (2015)

Drugs : from discovery to approval
by: Ng, Rick
Published: (2004)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session.
Published: (1980)

Drug compounding pharmacies risk and oversight issues
Published: (2013)

Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.
Published: (1983)

Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.
Published: (1983)

Modern drug discovery.
Published: (1998)

The Food and Drug Administration's generic drug review process.
Published: (2008)

Coloring of food, drugs, and cosmetics
by: Otterstätter, Gisbert, 1946-
Published: (1999)

Perspectives of drug manufacturers : investigational new drug and new drug applications.
Published: (1990)

Drug discovery : the evolution of modern medicines
by: Sneader, Walter
Published: (1985)

The risks of prescription drugs
Published: (2010)

Food and Drug Administration : approval and oversight of the drug Mifeprex : report to congressional requesters.
Published: (2008)

Rate-controlled drug administration and action
Published: (1986)

Multinational drug companies : issues in drug discovery and development
by: Spilker, Bert
Published: (1989)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2013)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

Drug design and discovery
Published: (1991)

Advisory Committee on the Food and Drug Administration final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.
Published: (1992)

Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.
Published: (1992)

Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.
Published: (1992)